Immune Response Post-SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept

Transplantation. 2021 Nov 1;105(11):e259-e260. doi: 10.1097/TP.0000000000003923.

Authors

Johan Noble^{1

2}, Antoine Langello¹, William Bouchut¹, Julien Lupo³, Dorothee Lombardo¹, Lionel Rostaing^{1

2}

Affiliations

¹ Nephrology, Hemodialysis, Apheresis, and Kidney Transplantation Department, University Hospital of Grenoble-Alpes, Grenoble, France.
² University Grenoble-Alpes, Grenoble, France.
³ Virology Department, University Hospital of Grenoble-Alpes, Grenoble, France.

No abstract available

Publication types

Letter
Comment

MeSH terms

Abatacept / therapeutic use
COVID-19*
Humans
Immunity
Kidney Transplantation* / adverse effects
RNA, Messenger
SARS-CoV-2
Transplant Recipients
Vaccination

Substances

RNA, Messenger
Abatacept